MHRA approves first monoclonal antibody treatment for COVID-19 in the UK
Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on […]
» Read moreHome »
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody […] The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […]
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19
Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay
